Cybin Inc. (NEO: CYBN)
Canada
· Delayed Price · Currency is CAD
13.65
+0.35 (2.63%)
Jan 21, 2025, 3:48 PM EST
Cybin Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
50
Market Cap
275.99M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | - | - | - |
Mar 31, 2023 | - | - | - |
Mar 31, 2022 | - | - | - |
Mar 31, 2021 | 864.00K | - | - |
Mar 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Green Thumb Industries | 1.51B |
Curaleaf Holdings | 1.83B |
WELL Health Technologies | 957.69M |
dentalcorp Holdings | 1.51B |
Trulieve Cannabis | 1.58B |
Sienna Senior Living | 867.55M |
Cronos Group | 150.26M |
Extendicare | 1.42B |
Cybin News
- 2 days ago - Cybin: Paradigm Changing Ambitions - Seeking Alpha
- 6 days ago - Cybin enters partnership agreement to conduct phase 3 trial for depression candidate - Seeking Alpha
- 6 days ago - Cybin Launches Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder - Business Wire
- 9 days ago - Cybin Highlights 2024 Accomplishments and Upcoming Milestones for 2025 - Business Wire
- 12 days ago - Cybin to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025 - Business Wire
- 14 days ago - Cybin files $650M mixed securities shelf - Seeking Alpha
- 6 weeks ago - Cybin Announces Poster Presentations at the 2024 American College of Neuropsychopharmacology Annual Meeting, Including CYB003 12-Month Efficacy Results - Business Wire
- 7 weeks ago - Cybin to Participate in Water Tower Research Fireside Chat on December 11, 2024 - Business Wire